105 related articles for article (PubMed ID: 1768784)
21. The in vitro effect of recombinant erythropoietin on cisdiamminodichloroplatinum-induced inhibition of murine erythroid stem cells.
Gebbia V; Valenza R; Rausa L
Anticancer Res; 1990; 10(6):1779-82. PubMed ID: 2285259
[TBL] [Abstract][Full Text] [Related]
22. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells.
Taniguchi S; Dai CH; Krantz SB
Exp Hematol; 1997 Mar; 25(3):193-8. PubMed ID: 9091293
[TBL] [Abstract][Full Text] [Related]
23. Effect of recombinant human interleukin 3, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor on human BFU-e in serum-free cultures.
Misago M; Chiba S; Kikuchi M; Tsukada J; Sato T; Oda S; Eto S
Int J Cell Cloning; 1989 Jan; 7(1):39-49. PubMed ID: 2465360
[TBL] [Abstract][Full Text] [Related]
24. Hematopoiesis in the rat: quantitation of hematopoietic progenitors and the response to iron deficiency anemia.
Kimura H; Finch CA; Adamson JW
J Cell Physiol; 1986 Feb; 126(2):298-306. PubMed ID: 3944211
[TBL] [Abstract][Full Text] [Related]
25. Effects of erythropoietin on mobilisation of haemopoietic progenitor cells.
Pettengell R; Woll PJ; Chang J; Coutinho L; Testa NG; Crowther D
Bone Marrow Transplant; 1994 Jul; 14(1):125-30. PubMed ID: 7951099
[TBL] [Abstract][Full Text] [Related]
26. Effects of cadmium on in vitro and in vivo erythropoiesis: erythroid progenitor cells (CFU-E), iron, and erythropoietin in cadmium-induced iron deficiency anemia.
Sakata S; Iwami K; Enoki Y; Kohzuki H; Shimizu S; Matsuda M; Moriyama T
Exp Hematol; 1988 Aug; 16(7):581-7. PubMed ID: 3391251
[TBL] [Abstract][Full Text] [Related]
27. Effect of cis-diamminedichloroplatinum on erythropoietin production and hematopoietic progenitor cells.
Rothmann SA; Paul P; Weick JK; McIntyre WR; Fantelli F
Int J Cell Cloning; 1985 Nov; 3(6):415-23. PubMed ID: 4067362
[TBL] [Abstract][Full Text] [Related]
28. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
Mayani H; Guilbert LJ; Janowska-Wieczorek A
Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo effects of recombinant human erythropoietin plus recombinant human G-CSF on human haemopoietic progenitor cells.
Pierelli L; Menichella G; Scambia G; Teofili L; Iovino S; Serafini R; Benedetti Panici P; Salerno G; Rumi C; Zini G
Bone Marrow Transplant; 1994 Jul; 14(1):23-30. PubMed ID: 7524905
[TBL] [Abstract][Full Text] [Related]
30. Effects of recombinant human tumor necrosis factor alpha, recombinant human gamma-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin alpha, and recombinant erythropoietin in serum-free cultures.
Lu L; Welte K; Gabrilove JL; Hangoc G; Bruno E; Hoffman R; Broxmeyer HE
Cancer Res; 1986 Sep; 46(9):4357-61. PubMed ID: 3089590
[TBL] [Abstract][Full Text] [Related]
31. Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19).
Potter CG; Potter AC; Hatton CS; Chapel HM; Anderson MJ; Pattison JR; Tyrrell DA; Higgins PG; Willman JS; Parry HF
J Clin Invest; 1987 May; 79(5):1486-92. PubMed ID: 3033026
[TBL] [Abstract][Full Text] [Related]
32. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
[TBL] [Abstract][Full Text] [Related]
33. Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin.
Sieff CA; Emerson SG; Mufson A; Gesner TG; Nathan DG
J Clin Invest; 1986 Jan; 77(1):74-81. PubMed ID: 3511093
[TBL] [Abstract][Full Text] [Related]
34. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
[TBL] [Abstract][Full Text] [Related]
35. Action of antithymocyte globulin on normal human erythroid progenitor cell proliferation in vitro: erythropoietic growth-enhancing factors are released from marrow accessory cells.
Mangan KF; D'Alessandro L; Mullaney MT
J Lab Clin Med; 1986 Apr; 107(4):353-64. PubMed ID: 2420910
[TBL] [Abstract][Full Text] [Related]
36. Hemotoxicity by prolonged etoposide administration to mice can be prevented by simultaneous growth factor therapy.
de Haan G; Engel C; Dontje B; Loeffler M; Nijhof W
Cancer Res; 1995 Jan; 55(2):324-9. PubMed ID: 7529132
[TBL] [Abstract][Full Text] [Related]
37. Ca++ and 1,25(OH)2D3 regulate in vitro and in vivo the response to human recombinant erythropoietin in CAPD patients.
Carozzi S; Ramello A; Nasini MG; Schelotto C; Caviglia PM; Cantaluppi A; Salit M; Lamperi S
Adv Perit Dial; 1990; 6():312-5. PubMed ID: 1982836
[TBL] [Abstract][Full Text] [Related]
38. Protection of zidovudine-induced toxicity against murine erythroid progenitor cells by vitamin E.
Gogu SR; Lertora JJ; George WJ; Hyslop NE; Agrawal KC
Exp Hematol; 1991 Aug; 19(7):649-52. PubMed ID: 1893952
[TBL] [Abstract][Full Text] [Related]
39. Stem cell factor enhances the survival of irradiated human bone marrow maintained in SCID mice.
Leigh BR; Webb S; Hancock SL; Knox SJ
Stem Cells; 1994 Jul; 12(4):430-5. PubMed ID: 7524895
[TBL] [Abstract][Full Text] [Related]
40. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
